An alternative method for the synthesis of 2′-halogeno-1′,2′-unsaturated uridine derivatives through syn-elimination of pivalic acid of 2′-halogeno- 2′-deoxy-1′-pivaloyloxyuracil nucleoside: preparation of its 2′-C-branched nucleosides

References

• Huryn, D. M.; Okabe, M. AIDS-Driven Nucleoside Chemistry. Chem. Rev. 1992, 92, 1745–1768. DOI:10.1021/cr00016a004.
   Web of Science ®Google Scholar
• Chu, C. K.; Baker, D. C.; Eds. Nucleosides and Nucleotides as Antitumor and Antiviral Agents. New York: Plenum Press, 1993.
   Google Scholar
• Franchetti, P.; Grifantini, M. Nucleoside and Non-Nucleoside IMP Dehydrogenase Inhibitors as Antitumor and Antiviral Agents. Curr. Med. Chem. 1999, 6, 599–614. DOI:10.1002/chin.199940260.
   PubMed Web of Science ®Google Scholar
• Ichikawa, E.; Kato, K. Sugar-Modified Nucleosides in Past 10 Year, A Review. CMC. 2001, 8, 385–423. DOI:10.2174/0929867013373471.
   PubMed Web of Science ®Google Scholar
• Simons C., Ed. Nucleoside Mimetics: Their Chemistry and Biological Properties. Amsterdam: Gordon and Breach Science Publishers, 2001.
   Google Scholar
• Ichikawa, E.; Kato, K. Synthesis of Oxcetanocin a and Related Unusual Nucleosides with Bis(Hydroxymethyl)-Branched Sugars. Synthesis 2002, 2002, 1–28. DOI:10.1055/s-2002-19289.
   Google Scholar
• Chu, C. K., Ed. Recent Advances in Nucleosides: Chemistry and Chemotherapy. Amsterdam: Elsevier B. V., 2002.
   Google Scholar
• Chu, C. K., Ed. Antiviral Nucleosides: Chemical Synthesis and Chemotherapy. Amsterdam: Elsevier B. V., 2003.
   Google Scholar
• Vaghefi, M. Ed. Nucleoside Triphosphates and Their Analogs: Chemistry, Biotechnology, and Biological Applications. Boca Raton, London, New York, Singapore: Tayler & Francis, 2005.
   Google Scholar
• Lawton, P. Purine Analogues as Antiparasitic Agents. Expert. Opin. Ther. Patents. 2005, 15, 987–994. DOI:10.1517/13543776.15.8.987.
   Web of Science ®Google Scholar
• Richardson, S.; K.; Howell, A. R.; Taboada, R. Synthesis and Properties of Psico-Nucleosides. Org. Prep. Proc. Int. 2006, 38, 101–176. DOI:10.1080/00304940609355987.
   Web of Science ®Google Scholar
• Peters, G. J., Ed. Deoxynucleoside Analogs in Cancer Therapy. New Jersey: Humana Press, 2006.
   Google Scholar
• Herdewijn, P., Ed. Modified Nucleosides in Biochemistry, Biotechnology and Medicine. Weinheim: Wiley-VCH Verlag GmbH & Co. KGaA, 2008.
   Google Scholar
• Romeo, G.; Chiacchio, U.; Corsaro, A.; Merino, P. Chemical Synthesis of Heterocyclic-Sugar Nucleoside Analogues. Chem. Rev. 2010, 110, 3337–3370. DOI:10.1021/cr800464r.
   PubMed Web of Science ®Google Scholar
• DeClercq, E., Ed. Antiviral Drug Design. Weinheim: Wiley-VCH Verlag GmbH & Co. KGaA, 2011.
   Google Scholar
• Calenbergh, S. V.; Pochet, S.; Munier-Lehman, H. Frug Design and Identification of Potent Leads against Mycobacterium tuberculosis Thymidine Monophosphate Kinase. CTMC. 2012, 12, 694–705. DOI:10.2174/156802612799984580.
   Google Scholar
• Merino, P., Ed. Chemical Synthesis of Nucleoside Analogues. Hoboken, New Jersey: John Wiley & Sons, 2013.
   Google Scholar
• De Clercq, E. Highlights in Antiviral Drug Research: antivirals at the Horizon. Med. Res. Rev. 2013, 33, 1215–1248. DOI:10.1002/med.21256.
   PubMed Web of Science ®Google Scholar
• Jordheim, L. P.; Durantel, D.; Zoulim, F.; Dumontet, C. Advances in the Development of Nucleoside and Nucleotide Analogues for Cancer and Viral Diseases. Nat. Rev. Drug Discov. 2013, 12, 447–464. DOI:10.1038/nrd4010.
   PubMed Web of Science ®Google Scholar
• De Clercq, E.; Li, G. Approved Antiviral Drugs Over the Past 50 Years. Clin. Microbiol. Rev. 2016, 29, 695–747. DOI:10.1128/CMR.00102-15.
   PubMed Web of Science ®Google Scholar
• Shelton, J.; Lu, X.; Hollenbaugh, J. A.; Cho, J. H.; Amblard, F.; Schinazi, R. F. Metabolism, Biochemical Actions, and Chemical Synthesis of Anticancer Nucleosides, Nucleotides, and Base Analogs. Chem. Rev. 2016, 116, 14379–14455. DOI:10.1021/acs.chemrev.6b00209.
   PubMed Web of Science ®Google Scholar
• Haraguchi, K.; Itoh, Y.; Tanaka, H. Carbon-Carbon Bond Formation at the Sugar Portion of Nucleosides: synthetic Potential of Unsaturated-Sugar Nucleosides. J. Syn. Org. Chem Jpn. 2003, 61, 974. DOI:10.5059/yukigoseikyokaishi.61.974.
   Web of Science ®Google Scholar
• Haraguchi, K.; Takeda, S.; Kubota, Y.; Kumamoto, H.; Tanaka, H.; Hamasaki, T.; E.; Baba, M.; Paintsil, E.; Cheng, Y.-C.; Urata, Y. Next Generation Anti-HIV Agent 4’-Ethynylstavudine: From The Bench To The Clinic. In Frontiers in Clinical Drug Research: HIV, Atta-ur-Rahman, J., ed.; Bentham Science Publishing: Sharjah, U.A.E., 2015; Vol. 1, pp. 123–184.
   Google Scholar
• Kumamoto, H.; Shindoh, S.; Tanaka, H.; Gen, E.; Haraguchi, K.; Kittaka, A.; Miyasaka, T. Stannyl Migration from the Base to the Sugar Portion of 1’,2’-Unsaturated Uridine: The First Example of Substitution at the 2’-Position. Tetrahedron Lett. 1998, 39, 3761–3764. DOI:10.1016/S0040-4039(98)00579-6.
   Web of Science ®Google Scholar
• Kumamoto, H.; Shindoh, S.; Tanaka, H.; Itoh, Y.; Haraguchi, K.; Gen, E.; Kittaka, A.; Miyasaka, T.; Kondo, M.; Nakamura, K. T. An Intramolecular Anionic Migration of a Stannyl Group from the 6-Position of 1-(2-deoxy-D-Erythro-Pent-1-Enofuranosyl)Uracil to the 2’-Position: Synthesis of 2’-Substituted 1’,2’-Unsaturated Uridines. Tetrahedron 2000, 56, 5363–5371. DOI:10.1016/S0040-4020(00)00441-5.
   Web of Science ®Google Scholar
• A part of the results of this study has been appeared inTetrahedron, 2000, 56, 5363–5371.
   Google Scholar
• Haraguchi, K.; Itoh, Y.; Tanaka, H.; Miyasaka, T. Preparation and Reactions of 2’- and 3’-Vinyl Bromides of Uracilnucleosides: Versatile Synthons for anti-HIV Agents. Tetrahedron Lett. 1991, 32, 3391–3394. DOI:10.1016/S0040-4039(00)92715-1.
   Web of Science ®Google Scholar
• Haraguchi, K.; Itoh, Y.; Tanaka, H.; Akita, T.; Miyasaka, T. Uracil and Adenine Nucleosides Having a 2’- or 3’-Bromovinyl Structure: highly Versatile Synthons for the Synthesis of 2’-C- and 3’-C-Branched 2’,3’-Unsaturated Derivatives. Tetrahedron 1993, 49, 1371–1390. DOI:10.1016/S0040-4020(01)90190-5.
   Web of Science ®Google Scholar
• Haraguchi, K.; Itoh, Y.; Tanaka, H.; Yamaguchi, K.; Miyasaka, T. Anomeric Manipulation of Nucleosides: Stereospecific Entry to 1’-C-Branched Uracil Nucleosides. Tetrahedron Lett. 1993, 34, 6913–6916. DOI:10.1016/S0040-4039(00)91829-X.
   Web of Science ®Google Scholar
• Itoh, Y.; Haraguchi, K.; Tanaka, H.; Gen, E.; Miyasaka, T. Divergent and Stereo-Controlled Approach to the Synthesis of Uracil Nucleosides Branched at the Anomeric Position. J. Org. Chem. 1995, 60, 656–662. DOI:10.1021/jo00108a031.
   Web of Science ®Google Scholar